Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1055 | 9558 | 38.3 | 70% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
154 | 58499 | INORGANIC CHEMISTRY//INORGANICA CHIMICA ACTA//JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
260 | 3715 | PLATINUM BASED DRUG//JM216//PLATINUM COMPLEXES |
4421 | 1715 | NAMI A//SCI INGN CHIM//BIOORGANOMETALLIC CHEMISTRY |
5294 | 1577 | NEPHROTOXICITY//SERV FARMACOL TOSSICOL//CISPLATIN NEPHROTOXICITY |
9676 | 1065 | CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R |
11215 | 933 | CISPLATIN RESISTANCE//PLATINUM DNA ADDUCTS//HUMAN OVARIAN CANCER CELL LINE |
19803 | 425 | LEHRSTUHL PHARMAZEUT CHEM 2//GRP RECH ONCOL ENDOCRINOL MOL//PORPHYRIN PLATINUM CONJUGATES |
31122 | 128 | LIPOSOMAL CISPLATIN//LIPOPLATIN//SPI 077 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CISPLATIN | Author keyword | 244 | 15% | 15% | 1450 |
2 | NAMI A | Author keyword | 77 | 96% | 0% | 24 |
3 | NEPHROTOXICITY | Author keyword | 50 | 12% | 4% | 380 |
4 | PLATINUM COMPLEXES | Author keyword | 50 | 23% | 2% | 189 |
5 | PLATINUMII COMPLEXES | Author keyword | 44 | 39% | 1% | 90 |
6 | PLATINUM BASED DRUG | Address | 44 | 100% | 0% | 16 |
7 | SATRAPLATIN | Author keyword | 37 | 73% | 0% | 29 |
8 | PLATFORM TRANSLAT CANC THER Y | Address | 36 | 79% | 0% | 23 |
9 | JM216 | Author keyword | 35 | 86% | 0% | 18 |
10 | TRANSPLATIN | Author keyword | 33 | 62% | 0% | 34 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CISPLATIN | 244 | 15% | 15% | 1450 | Search CISPLATIN | Search CISPLATIN |
2 | NAMI A | 77 | 96% | 0% | 24 | Search NAMI+A | Search NAMI+A |
3 | NEPHROTOXICITY | 50 | 12% | 4% | 380 | Search NEPHROTOXICITY | Search NEPHROTOXICITY |
4 | PLATINUM COMPLEXES | 50 | 23% | 2% | 189 | Search PLATINUM+COMPLEXES | Search PLATINUM+COMPLEXES |
5 | PLATINUMII COMPLEXES | 44 | 39% | 1% | 90 | Search PLATINUMII+COMPLEXES | Search PLATINUMII+COMPLEXES |
6 | SATRAPLATIN | 37 | 73% | 0% | 29 | Search SATRAPLATIN | Search SATRAPLATIN |
7 | JM216 | 35 | 86% | 0% | 18 | Search JM216 | Search JM216 |
8 | TRANSPLATIN | 33 | 62% | 0% | 34 | Search TRANSPLATIN | Search TRANSPLATIN |
9 | CARBOPLATIN | 30 | 11% | 3% | 269 | Search CARBOPLATIN | Search CARBOPLATIN |
10 | CISPLATIN RESISTANCE | 29 | 27% | 1% | 91 | Search CISPLATIN+RESISTANCE | Search CISPLATIN+RESISTANCE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CIS DIAMMINEDICHLOROPLATINUMII | 604 | 54% | 8% | 771 |
2 | ANTICANCER DRUG CISPLATIN | 259 | 63% | 3% | 262 |
3 | BISPLATINUM COMPLEXES | 215 | 82% | 1% | 126 |
4 | ANTITUMOR DRUG CIS DIAMMINEDICHLOROPLATINUMII | 211 | 78% | 1% | 139 |
5 | INTRASTRAND CROSS LINK | 209 | 84% | 1% | 113 |
6 | NAMI A | 195 | 81% | 1% | 118 |
7 | TRANS DIAMMINEDICHLOROPLATINUMII | 192 | 81% | 1% | 114 |
8 | ANTICANCER COMPLEXES | 174 | 74% | 1% | 130 |
9 | CANCER CELL CYTOTOXICITY | 130 | 93% | 1% | 50 |
10 | RUTHENIUMII ARENE COMPLEXES | 119 | 79% | 1% | 77 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Current status of platinum-based antitumor drugs | 1999 | 1191 | 159 | 87% |
The resurgence of platinum-based cancer chemotherapy | 2007 | 1269 | 96 | 44% |
Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates | 2012 | 129 | 71 | 92% |
Structure, recognition, and processing of cisplatin-DNA adducts | 1999 | 1487 | 294 | 58% |
Arene ruthenium complexes as anticancer agents | 2010 | 196 | 90 | 92% |
Noble metals in medicine: Latest advances | 2015 | 9 | 353 | 35% |
Synthetic Methods for the Preparation of Platinum Anticancer Complexes | 2014 | 33 | 315 | 82% |
Metal Complexes as DNA Intercalators | 2011 | 222 | 59 | 61% |
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies | 2008 | 382 | 143 | 71% |
New trends for metal complexes with anticancer activity | 2008 | 477 | 53 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLATINUM BASED DRUG | 44 | 100% | 0.2% | 16 |
2 | PLATFORM TRANSLAT CANC THER Y | 36 | 79% | 0.2% | 23 |
3 | LEHRSTUHL PHARMAZEUT CHEM 2 | 31 | 92% | 0.1% | 12 |
4 | SCI INGN CHIM | 23 | 15% | 1.5% | 146 |
5 | SERV FARMACOL TOSSICOL | 21 | 90% | 0.1% | 9 |
6 | JIANGSU PROV HITECH BIOMED | 12 | 35% | 0.3% | 27 |
7 | GRP RECH ONCOL ENDOCRINOL MOL | 11 | 69% | 0.1% | 9 |
8 | GENET MOL CITOGENET | 10 | 57% | 0.1% | 12 |
9 | EXPTL CHEMOTHER Y TOSHIMA KU | 9 | 83% | 0.1% | 5 |
10 | CAS ANALYT CHEM LIVING BIOSYST | 8 | 42% | 0.1% | 14 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000034866 | SACCHARINATE//SACCHARINATES//NUCLEOBASE COMPLEXES |
2 | 0.0000020426 | RESONANCE RAYLEIGH SCATTERING//RESONANCE LIGHT SCATTERING//DNA BINDING |
3 | 0.0000014579 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINFLUNINE//VINCRISTINE |
4 | 0.0000010692 | INTRAPERITONEAL CHEMOTHERAPY//CYTOREDUCTIVE SURGERY//PERITONEAL CARCINOMATOSIS |
5 | 0.0000010600 | CYCLOMETALLATION//CYCLOPALLADATION//PINCER COMPLEXES |
6 | 0.0000010051 | NITROSO COMPLEXES//DOUBLE COMPLEX SALT//RHENIUMIV COMPLEXES |
7 | 0.0000009428 | METALLOMICS//METALLOPROTEOMICS//SPE OMETRY SAMPLE PREPARAT MECHANIZAT GRP GEP |
8 | 0.0000008674 | GENTAMICIN//WEN PI TANG//GENTAMICIN INDUCED NEPHROTOXICITY |
9 | 0.0000007352 | GALLIUM NITRATE//GE 68 GA 68 GENERATOR//GALLIUM 68 |
10 | 0.0000006472 | PLATINUM GROUP ELEMENTS//AFFINITY ADSORPTION SOLID SUBSTRATE ROOM TEMPERATURE PHOSPHORIMETRY//NICKEL SULFIDE FIRE ASSAY |